Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 5;10(6):346-353.
doi: 10.9740/mhc.2020.11.346. eCollection 2020 Nov.

Assessment of the current practice of psychiatric pharmacists in the United States

Richard J Silvia  1   2   3   4   5   6   7 , Kelly C Lee  1 , Jolene R Bostwick  2 , Carla D Cobb  3 , Lisa W Goldstone  4 , Tera D Moore  5 , Gregory H Payne  6 , Jessica L Ho  7
Affiliations

Assessment of the current practice of psychiatric pharmacists in the United States

Richard J Silvia et al. Ment Health Clin. .

Abstract

Introduction: A comprehensive review of psychiatric pharmacy practice has never been performed in the United States. As psychiatric pharmacists become more involved in mental illness treatment, determining the current state of practice is important to help advance the specialty. The Professional Affairs Committee of the College of Psychiatric and Neurologic Pharmacists (CPNP) was charged with performing this review to define current psychiatric pharmacy practice.

Methods: An electronic survey was sent to all pharmacist members of CPNP and all nonmember Board Certified Psychiatric Pharmacists (BCPPs) in the United States in late summer 2019. The survey consisted of 36 questions across multiple domains to obtain information about respondents' education and training background, practice setting and type, and information about prescriptive authority and other areas. An initial e-mail invitation was sent along with 2 reminder e-mails over the subsequent 2 weeks.

Results: A total of 334 of 1015 pharmacists completed the survey (32.9%). Responders completed a postgraduate residency 77.8% of the time, and 88.3% were BCPP. Practice settings were split evenly between inpatient and outpatient practices or a combination of the 2. Among respondents, 46.5% reported having prescriptive authority as part of their practice, and 41.3% reported treating nonpsychiatric as well as psychiatric illnesses. Prescriptive authority was more likely in outpatient practices and in those treating nonpsychiatric illnesses.

Discussion: The current practice of psychiatric pharmacy is incredibly varied in terms of practice setting, activities performed, and services provided. Further exploration is needed to help determine the optimal role of psychiatric pharmacists.

Keywords: BCPP; practice model; prescriptive authority; professional affairs; psychiatric pharmacist.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Percentage of respondents by geographic region (n = 320; missing geographic data for 14 respondents)
FIGURE 2
FIGURE 2
Psychiatric pharmacist management of nonpsychiatric conditions (N/A = not applicable)
FIGURE 3
FIGURE 3
Clinical activities performed by psychiatric pharmacists in at least 50% of patients
See this image and copyright information in PMC

References

    1. Substance Abuse and Mental Health Services Administration. US Department of Health and Human Services; Substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use. [Internet] [cited 2020 Sep 12]. Available from: https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSD....
    1. Hampton LM, Daubresse M, Chang H-Y, Alexander GC, Budnitz DS. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry. 2014;71(9):1006–14. DOI: 10.1001/jamapsychiatry.2014.436 PubMed PMID: 25006837. - DOI - PMC - PubMed
    1. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications. JAMA Psychiatry. 2015;72(4):334–41. DOI: 10.1001/jamapsychiatry.2014.2502 PubMed PMID: 25671328 PubMed Central PMCID: PMC4461039. - DOI - PMC - PubMed
    1. Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry. 2009;70(Suppl 3):22–9. DOI: 10.4088/JCP.7075su1c.04 PubMed PMID: 19570498. - DOI - PubMed
    1. Bulloch AGM, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):47–56. DOI: 10.1007/s00127-009-0041-5 PubMed PMID: 19347238. - DOI - PubMed